NCT06068335RecruitingAccepts Healthy Volunteers
Innate Immunity in Allergic Asthma
University of Central Florida
Start Date
10/18/2021
Completion Date
6/1/2025
Summary
The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* Participants must be at least 18 years of age
* no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma.
Exclusion Criteria:
* Pregnant women and prisoners will be excluded from the study.
* Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded.
Conditions
Asthma
Locations
University of Central Florida
Orlando, Florida 32816
United States